Disease management programs improve outcomes in subjects with chronic obstructive pulmonary disease (COPD), but their effect in subjects with alpha-1 antitrypsin deficiency (AATD) has not been evaluated. To assess the impact of a disease management program, applicable to subjects with AATD-associated COPD throughout the United States, on exacerbations, healthcare resource utilization and health-related quality of life (HRQoL). The Alpha-1 Disease Management and Prevention Program (ADMAPP) consisted of comprehensive written educational patient-directed material for self-study and treatment plans. Program reinforcement was performed through monthly phone calls by specialized coordinators. Outcomes were collected prospectively for 12 months be...
Purpose: Alpha-1 antitrypsin deficiency is associated with the development of chronic obstructive pu...
Background: Alpha-1-Antitrypsin Deficiency (AATD) is an economically unexplored genetic disease. Met...
Setting: About 1–3% of patients with diagnosed chronic obstructive pulmonary disease (COPD) is predi...
Rationale: Alpha-1 antitrypsin deficiency (AATD) is characterized by decreased circulating levels or...
BACKGROUND Trials of disease modifying therapies in Chronic Obstructive Pulmonary Disease (COPD) ...
SummaryBackgroundThe frequency, characteristics and impact of acute exacerbations in patients with a...
Chronic obstructive pulmonary disease (COPD) is a progressive disease of the lungs and is the fourth...
Patients with inherited alpha-1-antitrypsin (AAT) deficiency (ZZ-AATD) and severe chronic obstructiv...
BACKGROUND Alpha-1 antitrypsin deficiency (AATD) is a rare genetic condition predisposing individ...
Alpha-1 antitrypsin deficiency (AATD) is an important risk factor for development of chronic obstruc...
Management of lung disease in patients with alpha-1 antitrypsin deficiency (AATD) includes both non-...
Management of lung disease in patients with alpha-1 antitrypsin deficiency (AATD) includes both non-...
BACKGROUND: Alpha-1-Antitrypsin Deficiency (AATD) is an economically unexplored genetic disease. MET...
Objective: Severe exacerbations in alpha-1-antitrypsin (AAT)-deficient patients with chronic obstruc...
The objective of this study was to assess the effectiveness of an education program and telephone ca...
Purpose: Alpha-1 antitrypsin deficiency is associated with the development of chronic obstructive pu...
Background: Alpha-1-Antitrypsin Deficiency (AATD) is an economically unexplored genetic disease. Met...
Setting: About 1–3% of patients with diagnosed chronic obstructive pulmonary disease (COPD) is predi...
Rationale: Alpha-1 antitrypsin deficiency (AATD) is characterized by decreased circulating levels or...
BACKGROUND Trials of disease modifying therapies in Chronic Obstructive Pulmonary Disease (COPD) ...
SummaryBackgroundThe frequency, characteristics and impact of acute exacerbations in patients with a...
Chronic obstructive pulmonary disease (COPD) is a progressive disease of the lungs and is the fourth...
Patients with inherited alpha-1-antitrypsin (AAT) deficiency (ZZ-AATD) and severe chronic obstructiv...
BACKGROUND Alpha-1 antitrypsin deficiency (AATD) is a rare genetic condition predisposing individ...
Alpha-1 antitrypsin deficiency (AATD) is an important risk factor for development of chronic obstruc...
Management of lung disease in patients with alpha-1 antitrypsin deficiency (AATD) includes both non-...
Management of lung disease in patients with alpha-1 antitrypsin deficiency (AATD) includes both non-...
BACKGROUND: Alpha-1-Antitrypsin Deficiency (AATD) is an economically unexplored genetic disease. MET...
Objective: Severe exacerbations in alpha-1-antitrypsin (AAT)-deficient patients with chronic obstruc...
The objective of this study was to assess the effectiveness of an education program and telephone ca...
Purpose: Alpha-1 antitrypsin deficiency is associated with the development of chronic obstructive pu...
Background: Alpha-1-Antitrypsin Deficiency (AATD) is an economically unexplored genetic disease. Met...
Setting: About 1–3% of patients with diagnosed chronic obstructive pulmonary disease (COPD) is predi...